FDA Inspection 1201249 — University of Washington Med Center - Roosevelt
The FDA completed an inspection of University of Washington Med Center - Roosevelt on March 2, 2023 in Seattle, WA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 2, 2023
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Seattle, WA (United States)